Table 7 |
|||||||
|
Sarcoplasmic reticulum fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months. |
|||||||
|
Duration (months) |
2 |
2 |
2 |
6 |
6 |
6 |
|
|
|
|||||||
|
Dietary groups |
CTL |
DHA |
ALA |
CTL |
DHA |
ALA |
|
|
|
|||||||
|
Fatty acids |
CI |
||||||
|
16:0 |
9.1 ± 0.36c |
11.2 ± 0.35a |
10.5 ± 0.33b |
9.5 ± 0.46b |
11 ± 0.22a |
10.2 ± 0.05ab |
- |
|
18:0 |
22.9 ± 0.31 |
22.5 ± 0.36 |
22.3 ± 0.26 |
23.2 ± 0.4 |
22.6 ± 0.22 |
22.8 ± 0.12 |
- |
|
18:1 n-9 |
4.6 ± 0.18a |
3.7 ± 0.13b |
4.9 ± 0.10a |
4.1 ± 0.13a ** |
3.4 ± 0.14b |
4.1 ± 0.1a ** |
- |
|
18:1 n-7 |
2.9 ± 0.06a |
2.3 ± 0.05c |
2.6 ± 0.07b |
2.5 ± 0.08a *** |
2.1 ± 0.07b *** |
2.6 ± 0.05a |
$ |
|
18:2 n-6 |
25.8 ± 0.54b |
20.9 ± 0.76c |
26.9 ± 0.61a |
26.1 ± 0.45a |
23.4 ± 0.36b * |
26.8 ± 0.65a |
- |
|
18:3 n-3 |
<0.01 |
<0.01 |
1.3 ± 0.05 |
<0.01 |
<0.01 |
1.2 ± 0.04** |
|
|
20:4 n-6 |
23.3 ± 0.57a |
11.7 ± 0.27b |
14.8 ± 0.41b |
24.4 ± 0.64a |
11.8 ± 0.51b |
15.1 ± 0.58b |
- |
|
20:5 n-3 |
<0.01 |
0.9 ± 0.04 |
1.1 ± 0.28 |
<0.01 |
1.0 ± 0.03b |
1.5 ± 0.03a* |
|
|
22:4 n-6 |
1.3 ± 0.03 |
<0.01 |
<0.01 |
1.1 ± 0.04*** |
<0.01 |
<0.01 |
|
|
22:5 n-6 |
3.1 ± 0.23a |
0.8 ± 0.02a |
<0.01 |
2.8 ± 0.24b |
0.7 ± 0.01a |
<0.01 |
|
|
22:5 n-3 |
0.7 ± 0.03b |
0.8 ± 0.04b |
3.5 ± 0.13a |
0.6 ± 0.03b |
0.7 ± 0.03b |
3.9 ± 0.06a * |
$ |
|
22:6 n-3 |
4.2 ± 0.16c |
23 ± 0.70a |
8.9 ± 0.46b |
3.2 ± 0.14c |
20.9 ± 0.24a ** |
9 ± 0.36b |
$ |
|
|
|||||||
|
SFA |
32.8 ± 0.41 |
34.4 ± 0.32 |
33.8 ± 0.33 |
33.2 ± 0.84 |
34.2 ± 0.12 |
33.6 ± 0.09 |
- |
|
MUFA |
8.2 ± 0.24a |
6.9 ± 0.16b |
8.6 ± 0.28a |
7.8 ± 0.30a |
6.6 ± 0.23b |
8 ± 0.08a |
- |
|
PUFA |
59 ± 0.63 |
58.7 ± 0.38 |
57.6 ± 0.52 |
58.9 ± 1.11 |
59.1 ± 0.26 |
58.4 ± 0.09 |
- |
|
n-6 PUFA |
54 ± 0.65a |
34 ± 0.79c |
42.7 ± 0.66b |
54.9 ± 1.01a |
36.4 ± 0.43c * |
42.6 ± 0.35b |
- |
|
n-3 PUFA |
5 ± 0.17c |
24.8 ± 0.70a |
14.8 ± 0.68b |
4 ± 0.16c * |
22.7 ± 0.24a * |
15.7 ± 0.36b |
$ |
|
LA/AA |
1.1 ± 0.05b |
1.8 ± 0.08a |
1.8 ± 0.07a |
1.1 ± 0.02b |
2 ± 0.10a |
1.8 ± 0.10a |
- |
|
AA/DHA |
5.6 ± 0.20a |
0.5 ± 0.02c |
1.7 ± 0.09b |
7.7 ± 0.26a *** |
0.6 ± 0.03c |
1.7 ± 0.10b |
$ |
|
n-6/n-3 ratio |
10.9 ± 0.43a |
1.4 ± 0.07c |
2.9 ± 0.18b |
13.9 ± 0.41a *** |
1.6 ± 0.03c |
2.7 ± 0.09b |
$ |
|
P/S ratio |
1.8 ± 0.04 |
1.7 ± 0.03 |
1.7 ± 0.03 |
1.7 ± 0.07 |
1.7 ± 0.01 |
1.7 ± 0.01 |
- |
|
|
|||||||
|
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. alpha linolenic acid-rich diet. Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05. |
|||||||
|
Brochot et al. Nutrition & Metabolism 2009 6:14 doi:10.1186/1743-7075-6-14 |
|||||||